GVR Report cover Medical Oxygen Concentrators & Oxygen Cylinders Market Size, Share & Trends Report

Medical Oxygen Concentrators & Oxygen Cylinders Market Size, Share & Trends Analysis Report By Product, By Technology, By End User, By Region, And Segment Forecasts, 2020 - 2026

  • Report ID: 978-1-68038-457-4
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2018
  • Industry: Healthcare

Report Overview

The global medical oxygen concentrators and oxygen cylinders market size was valued at USD 2.9 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% from 2020 to 2026. Growing incidence of Chronic Obstructive Pulmonary Diseases (COPDs) and increasing technological advancements for the miniaturization of the oxygen concentrators are some of the key factors expected to drive the market over the forecast period.

U.S. medical oxygen concentrators & oxygen cylinders market size

In addition, manufacturers are introducing new technologies in concentrators that aim to improve the quality of care. For instance, in February 2018, GCE healthcare launched a remote monitoring platform, called Clarity for oxygen concentrators. The technology monitors the patients and regularly sends the data related to oxygen purity, device location, and battery life to provider and patient’s family members. Such technological advancements in portable concentrators attract more customers and hence create demand for oxygen concentrators.

Increasing prevalence of COPD and other lung disorders is another key factor boosting the market growth. According to the U.S. government, in 2017, over 16 million U.S. adults were diagnosed with COPD, around 9 million with chronic bronchitis, and 3.5 million with emphysema. In addition, COPD is the cause of over 7 million emergency department visits each year in the U.S.The long-term use of supplemental oxygen has improved the survival rate of patients with COPD. Hence, rising prevalence of COPD and other lung diseases and dependence of COPD patients on oxygen therapy products are among the key factors boosting the demand for oxygen concentrators and cylinders.

Furthermore, several campaigns and programs have been launched by many government and non-government organizations to educate citizens about COPD and ways to manage it. For instance, the National Heart, Lung, and Blood Institute (NHLBI) and the WHO formed the Global Initiative for Chronic Obstructive Lung Disease (GOLD) with an objective to increase awareness about COPD and help people in management of the disease. Moreover, the American Lung Association promotes awareness about COPD.

Growing healthcare expenditure, better medical facilities, and rapid technological advancements have helped increase the life expectancy of people globally. However, geriatric population is more susceptible to cardiovascular disorders and lung diseases owing to a weak immune system. Elderly people have a less pulmonary reserve and reduced cough strength due to anatomic changes and muscle loss. Hence, they are at a high risk of developing lung disorders and various breathing problems. According to the National Institutes of Health Census Bureau, in 2016, around 8.5% of the people worldwide, i.e., around 617 million people were aged 65 and above. Moreover, this number is expected to reach 1.6 billion by 2050.

Furthermore, the oxygen concentrators market is directly impacted by the COVID-19 outbreak, which is a resultant of a significant shortage of ventilators globally. To overcome this shortage, biomedical engineers and scientists have developed makeshift devices to mimic the basic functionality of ventilators using existing devices, such as oxygen concentrators, anesthesia machines, PAP devices, and manual resuscitators. Furthermore, the U.S. FDA has allowed the usage of these concentrators under the Emergency Use Authorization scheme, which will significantly increase the demand for oxygen concentrators in the coming quarters.

As most of the critical cases of COVID-19 require some form of artificial ventilation, demand for wall-mounted oxygen concentrators, and piped/canned oxygen is witnessing a significant rise. The same is evident in the recent movements undertaken by market participants. For instance, Linde, one of the largest medical gas companies, is rapidly increasing its oxygen production. The company is also working closely with providers across the globe to anticipate the demand and ramp up the deliveries. 

Furthermore, ResMed, one of the leading participants of the oxygen concentrators market, is poised to witness significant growth in the next 2-3 quarters due to its large portfolio of respiratory devices. To meet the rapidly increasing global demand, the company is increasing its masks manufacturing capacities by 10 times and ventilator manufacturing by 2-3 times. The company has a capacity of manufacturing nearly 1 million devices annually, which will certainly help the company to play a significant role to curb this situation.

Product Insights

Portable medical oxygen concentrators accounted for the largest revenue share of 35.2% in 2019. Increasing prevalence of respiratory disorders, such as asthma, COPD, and pneumonia, is expected to boost the usage of portable oxygen concentrators over the forecast period. Furthermore, a rise in the number of air travelers and increasing approvals for portable concentrators from the Federal Aviation Administration (FAA) are expected to drive the portable concentrators segment.

The stationary medical oxygen concentrators are expected to witness slower growth as compared to portable devices. The older people with limited movements opt for these medical devices. Hence, its adoption in countries with a large geriatric population is increasing. Moreover, stationary concentrators are more economical, thus their adoption is higher in developing and underdeveloped countries, wherein healthcare expenditure and standard of living are still low.

In addition, oxygen cylinders are expected to witness significant growth over the forecast period. Purity of oxygen supplied by these medical devices and their simple structure are some of the key factors aiding their growth. Oxygen cylinders, when compared to concentrators, have finite oxygen supply. However, these medical devices do not require any battery to operate. In addition, the oxygen supplied by these cylinders has higher purity as compared to that supplied by concentrators.

Technology Insights

Continuous flow accounted for the largest revenue share of 87% in 2019. Rapid technological advancement pertaining to new product development is expected to boost the usage of medical oxygen concentrators. Furthermore, ongoing use of respiratory equipment for oxygen therapies is anticipated to boost the segment growth. Elderly population and bedridden patients are the main targeted groups for continuous flow oxygen concentrators. In addition, the devices are not fitted with any breath detection technology, hence they are cheaper as compared to pulse flow technology.

Pulse flow technology in oxygen concentrators is expected to witness the fastest growth over the forecast period owing to technological advancements. The technology is more efficient and convenient as compared to continuous flow and is majorly used by the patients who take 450 mL to 1250 mL per minute of oxygen in short pulses. It is mostly suitable for users with an active lifestyle. Hence, working professionals, regular air travelers, and sports players suffering from COPD or other breathing issues are rapidly opting for concentrators based on this technology.

End-user Insights

In terms of revenue, the home care segment dominated the overall medical oxygen concentrators and oxygen cylinders market with a revenue share of 56.4% in 2019. Increasing demand for home healthcare oxygen therapies, coupled with rising demand for pure oxygen and technological advancements, such as miniaturization of these medical devices, is expected to contribute to the segment growth over the forecast period. Improving standard of living and growing usage of home-based therapy, especially in developed regions, such as North America and Europe, are the major factors driving the segment. Moreover, presence of a large geriatric population in countries, such as Germany, Japan, Italy, Monaco, and Austria, is expected to fuel segment growth over the forecast period.

Global medical oxygen concentrators & oxygen cylinders market share

The non-homecare segment has witnessed significant growth in the year 2020 due to the sudden outbreak of COVID-19 across the world, which has increased the demand for supplemental oxygen therapy products, such as wall-mounted and repurpose home oxygen equipment, to combat against this pandemic. The non-homecare segment mainly includes the use of oxygen therapy products outside home settings, such as hospitals and clinics. Rise in the number of hospitals and other healthcare settings and high per capita healthcare expenditure in North America and Europe are the key factors influencing this segment's growth.

Regional Insights

In 2019, North America accounted for the largest revenue share of 32.4%. Growing geriatric population in the region is one of the significant factors contributing to market growth. According to the data published by the UN, in 2014, it was estimated that over 70 million people in North America were above 60 years of age. This demographic is prone to various respiratory disorders due to weaker immunity system and low oxygen intake capacity. Furthermore, government initiatives such as the authorized use of portable oxygen concentrators during air travel by the Federal Aviation Administration (FAA) and increasing prevalence of severe chronic obstructive pulmonary disorder due to unhealthy lifestyles are contributing to the regional market growth.

Asia Pacific is anticipated to be the most lucrative market during the forecast period. Key factors fueling regional market growth include rapidly increasing geriatric population and prevalence of lung disorders. It is estimated that one in every four people in the region will be over 60 years of age by 2050. Living and health standards have increased significantly in the more developed economies of the region. Increase in life expectancy, healthcare expenditure, and awareness regarding available technologies are some of the factors expected to contribute to regional market growth over the forecast period.

Key Companies & Market Share Insights

The medical oxygen concentrators and cylinders industry is highly fragmented due to the presence of a number of large, small, and local players. Companies are significantly increasing their manufacturing capacities and training efforts to meet the rising demand for these concentrators and cylinders. For instance, ResMed, Invacare Corporation, and CAIRE, Inc. are some of the leading companies in the oxygen concentrators market that are poised to witness significant growth in the next 2-3 quarters of 2020 owing to their large portfolio of respiratory devices. Some of the prominent players in the medical oxygen concentrators & oxygen cylinders market include:

  • Drive DeVilbiss Healthcare, Inc.

  • Philips Healthcare

  • Invacare Corporation

  • Nidek Medical

  • Inogen, Inc.

  • AirSep Corporation

  • ResMed

Medical Oxygen Concentrators & Oxygen Cylinders Market Report Scope

Report Attribute


Market size value in 2020

USD 3.92 billion

Revenue forecast in 2026

USD 3.71 billion

Growth Rate

CAGR of 4.2% from 2020 to 2026

Base year for estimation


Historical data

2014 - 2018

Forecast period

2020 - 2026

Quantitative units

Revenue in USD Million, Volume in 000’ Units, and CAGR from 2020 to 2026

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, Technology, End User, and Region

Regional scope

North America, Europe, Asia Pacific, Latin America, and MEA

Country scope

U.S., Canada, U.K., Germany, France, Spain, Italy, Russia, Japan, China, Australia, India, Singapore, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE

Key companies profiled

Drive DeVilbiss Healthcare, Inc.; Philips Healthcare; Invacare Corporation; Nidek Medical; Inogen, Inc.; AirSep Corporation; and ResMed.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts volume and revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research, Inc. has segmented the global medical oxygen concentrators & oxygen cylinders market report on the basis of product, technology, end-use, and region:

  • Product Outlook (Volume, 000’ Units; Revenue, USD Million, 2014 - 2026)

    • Portable Oxygen Concentrator & Cylinders

    • Stationary Oxygen Concentrator & Cylinders

    • Oxygen Concentrator & Cylinders

  • Technology Outlook (Volume, 000’ Units; Revenue, USD Million, 2014 - 2026)

    • Continuous Flow

    • Pulse Flow

  • End-user Outlook (Volume, 000’ Units; Revenue, USD Million, 2014 - 2026)

    • Home Care

    • Non-homecare

  • Regional Outlook (Volume, 000’ Units; Revenue, USD Million, 2014 - 2026)

    • North America

      • The U.S.

      • Canada

    • Europe

      • The U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Singapore

      • South Korea

    • Latin America

      • Mexico

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon